FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

André Rogatko

Research Profile

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

Activities & Behaviors

Clinical Trials, Phase I as Topic

Co-author Network

Publications

TOP 3
R D Harvey; A Akintayo; Z Chen; B El-Rayes; M P Fanucchi; Fadlo R Khuri; C M Lewis; P Nadella; Taofeek Owonikoko; S S Ramalingam; André Rogatko; Dong M Shin; Mourad Tighiouart; J S Kauh
A phase 1 Bayesian dose selection study of bortezomib and sunitinib in patients with refractory solid tumor malignancies.
Igor A Astsaturov; Neal J Meropol; R Katherine Alpaugh; Barbara Burtness; Jonathan D Cheng; Sue McLaughlin; André Rogatko; Zhiheng Xu; James C Watson; Louis M Weiner; Steven J Cohen
Phase II and coagulation cascade biomarker study of bevacizumab with or without docetaxel in patients with previously treated metastatic pancreatic adenocarcinoma.
Haibin Wang; Erik Bouzyk; Anna Kuehn; Susan Muller; Zhengjia Chen; Fadlo R Khuri; Dong M Shin; André Rogatko; Mourad Tighiouart
caGrid-Enabled caBIG Silver Level Compatible Head and Neck Cancer Tissue Database System.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of André Rogatko (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: R D Harvey; A Akintayo; Z Chen; B El-Rayes; M P Fanucchi; Fadlo R Khuri; C M Lewis; P Nadella; Taofeek Owonikoko; S S Ramalingam; André Rogatko; Dong M Shin; Mourad Tighiouart; J S Kauh
A phase 1 Bayesian dose selection study of bortezomib and sunitinib in patients with refractory solid tumor malignancies.
British journal of cancer 2013;108(4):762-5.
2011: Igor A Astsaturov; Neal J Meropol; R Katherine Alpaugh; Barbara Burtness; Jonathan D Cheng; Sue McLaughlin; André Rogatko; Zhiheng Xu; James C Watson; Louis M Weiner; Steven J Cohen
Phase II and coagulation cascade biomarker study of bevacizumab with or without docetaxel in patients with previously treated metastatic pancreatic adenocarcinoma.
American journal of clinical oncology 2011;34(1):70-5.
2010: Haibin Wang; Erik Bouzyk; Anna Kuehn; Susan Muller; Zhengjia Chen; Fadlo R Khuri; Dong M Shin; André Rogatko; Mourad Tighiouart
caGrid-Enabled caBIG Silver Level Compatible Head and Neck Cancer Tissue Database System.
The open medical informatics journal 2010;4():171-8.
2009: Hossein Borghaei; Katherine Alpaugh; Gunnar Hedlund; Göran Forsberg; Corey Langer; André Rogatko; Robert Hawkins; Svein Dueland; Ulrik Lassen; Roger B Cohen
Phase I dose escalation, pharmacokinetic and pharmacodynamic study of naptumomab estafenatox alone in patients with advanced cancer and with docetaxel in patients with advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(25):4116-23.
2008: Steven J Cohen; R Katherine Alpaugh; Irma Palazzo; Neal J Meropol; André Rogatko; Zhiheng Xu; John P Hoffman; Louis M Weiner; Jonathan D Cheng
Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma.
Pancreas 2008;37(2):154-8.
2008: Kathy P Parker; Donald L Bliwise; Maria Ribeiro; Sanjay R Jain; Catherine I Vena; Mary Kay Kohles-Baker; André Rogatko; Zhiheng Xu; Wayne B Harris
Sleep/Wake patterns of individuals with advanced cancer measured by ambulatory polysomnography.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(15):2464-72.
2007: André Rogatko; David Schoeneck; William Jonas; Mourad Tighiouart; Fadlo R Khuri; Alan Porter
Translation of innovative designs into phase I trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(31):4982-6.
2007: Gary M Freedman; Neal J Meropol; Elin R Sigurdson; John Hoffman; Elaine Callahan; Robert Price; Jonathan Cheng; Steve Cohen; Nancy Lewis; Deborah Watkins-Bruner; André Rogatko; Andre Konski
Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer.
International journal of radiation oncology, biology, physics 2007;67(5):1389-93.
2006: Steven J Cohen; R Katherine Alpaugh; Steve Gross; S Mark O'Hara; Denis A Smirnov; Leon W M M Terstappen; W Jeffrey Allard; Maryann Bilbee; Jonathan D Cheng; John P Hoffman; Nancy L Lewis; Ann Pellegrino; André Rogatko; Elin R Sigurdson; Hao Wang; James C Watson; Louis M Weiner; Neal J Meropol
Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer.
Clinical colorectal cancer 2006;6(2):125-32.
2005: André Rogatko; James S Babb; Mourad Tighiouart; Fadlo R Khuri; Gary R Hudes
New paradigm in dose-finding trials: patient-specific dosing and beyond phase I.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(15):5342-6.
2005: Edward S Kim; Merrill S Kies; Frank V Fossella; Bonnie S Glisson; Sara Zaknoen; Paul Statkevich; Reginald F Munden; Carmen Summey; Katherine M W Pisters; Vassiliki A Papadimitrakopoulou; Mourad Tighiouart; André Rogatko; Fadlo R Khuri
Phase II study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in patients with taxane-refractory/resistant nonsmall cell lung carcinoma.
Cancer 2005;104(3):561-9.
2005: Mourad Tighiouart; André Rogatko; James S Babb
Flexible Bayesian methods for cancer phase I clinical trials. Dose escalation with overdose control.
Statistics in medicine 2005;24(14):2183-96.
2005: Mark L Sundermeyer; Neal J Meropol; André Rogatko; Hao Wang; Steven J Cohen
Changing patterns of bone and brain metastases in patients with colorectal cancer.
Clinical colorectal cancer 2005;5(2):108-13.
2005: Leslie E Carlini; Neal J Meropol; John Bever; Michael L Andria; Todd Hill; Philip Gold; André Rogatko; Hao Wang; Rebecca L Blanchard
UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(3):1226-36.
2004: Gloria J Morris; Michael Millenson; Kristin Padavic-Shaller; Hao Wang; André Rogatko; James Clyde; Robert L Boyd; Gwen Yeslow; Theresa Halbherr; Russell J Schilder; Mitchell R Smith
Phase II study of fludarabine and alpha-interferon in patients with low-grade non-Hodgkin's lymphoma.
Haematologica 2004;89(12):1484-91.
2004: Hossein Borghaei; Michael Millenson; Russell J Schilder; Mitchell Alden; André Rogatko; Hao Wang; Kristin Padavic-Shaller; Mitchell R Smith
Phase II study of paclitaxel and estramustine in patients with recurrent and refractory non-Hodgkin lymphoma.
Cancer 2004;101(9):2034-41.
2004: André Rogatko; James S Babb; Hao Wang; Michael J Slifker; Gary R Hudes
Patient characteristics compete with dose as predictors of acute treatment toxicity in early phase clinical trials.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(14):4645-51.
2004: Steven J Cohen; James Gallo; Nancy L Lewis; R Katherine Alpaugh; Louis Gentner; André Rogatko; Gwen Yeslow; Jessie Schol; Tom Verhaeghe; Peter Zannikos; Peter A Palmer; Louis M Weiner; Neal J Meropol
Phase I and pharmacokinetic study of the farnesyltransferase inhibitor R115777 in combination with irinotecan in patients with advanced cancer.
Cancer chemotherapy and pharmacology 2004;53(6):513-8.
2004: Jonathan D Cheng; James S Babb; Corey Langer; Steinar Aamdal; Francisco Robert; Lars Rupert Engelhardt; Olov Fernberg; Joan Schiller; Goran Forsberg; R Katherine Alpaugh; Louis M Weiner; André Rogatko
Individualized patient dosing in phase I clinical trials: the role of escalation with overdose control in PNU-214936.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(4):602-9.
2004: Nancy L Lewis; M Mullaney; Kenneth F Mangan; Thomas R Klumpp; André Rogatko; Dominique Broccoli
Measurable immune dysfunction and telomere attrition in long-term allogeneic transplant recipients.
Bone marrow transplantation 2004;33(1):71-8.
2003: Robert M Sharkey; Arnold Brenner; Jack Burton; George Hajjar; Stephen P Toder; Abass Alavi; Alexander Matthies; Donald E Tsai; Stephen J Schuster; Edward A Stadtmauer; Myron S Czuczman; Dominick Lamonica; Françoise Kraeber-Bodere; Beatrice Mahe; Jean-François Chatal; André Rogatko; George Mardirrosian; David M Goldenberg
Radioimmunotherapy of non-Hodgkin's lymphoma with 90Y-DOTA humanized anti-CD22 IgG (90Y-Epratuzumab): do tumor targeting and dosimetry predict therapeutic response?
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(12):2000-18.
2003: Tommy Brown; Elin R Sigurdson; André Rogatko; Dominique Broccoli
Telomerase inhibition using azidothymidine in the HT-29 colon cancer cell line.
Annals of surgical oncology 2003;10(8):910-5.
2003: Steven J Cohen; Linus Ho; Sulabha Ranganathan; James L Abbruzzese; R Katherine Alpaugh; Mary Beard; Nancy L Lewis; Susan McLaughlin; André Rogatko; Juan Jose Perez-Ruixo; Amanda M Thistle; Tom Verhaeghe; Hao Wang; Louis M Weiner; John J Wright; Gary R Hudes; Neal J Meropol
Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(7):1301-6.
2003: Naomi B Haas; Mitchell Smith; Nancy Lewis; Lynn Littman; Gwen Yeslow; Indira Joshi; Anthony J Murgo; Joyce Bradley; Robert Gordon; Hao Wang; André Rogatko; Gary R Hudes
Weekly bryostatin-1 in metastatic renal cell carcinoma: a phase II study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1):109-14.
2002: André Rogatko; Michael J Slifker; James S Babb
Hardy-Weinberg equilibrium diagnostics.
Theoretical population biology 2002;62(3):251-7.
2002: Jonathan D Cheng; Roland L Dunbrack; Matthildi Valianou; André Rogatko; R Katherine Alpaugh; Louis M Weiner
Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model.
Cancer research 2002;62(16):4767-72.
2001: James S Babb; André Rogatko
Patient specific dosing in a cancer phase I clinical trial.
Statistics in medicine 2001;20(14):2079-90.
2001: Naomi Haas; B Roth; CA Garay; Gwen Yeslow; M Entmacher; A Weinstein; André Rogatko; James Babb; C Minnitti; D Flinker; T Gillon; Gary R Hudes
Phase I trial of weekly paclitaxel plus oral estramustine phosphate in patients with hormone-refractory prostate cancer.
Urology 2001;58(1):59-64.
2001: Margaret von Mehren; Philip M Arlen; James L Gulley; André Rogatko; Harry S Cooper; Neal J Meropol; R Katherine Alpaugh; M Davey; Susan McLaughlin; Mary Beard; Kwong-Yok Tsang; J Schlom; Louis M Weiner
The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(5):1181-91.
2001: Russell J Schilder; James M Gallo; Michael Millenson; Michael A Bookman; Louis M Weiner; André Rogatko; B Rogers; K Padavic-Shallers; MP Boente; Norman G Rosenblum; Andrea L Adams; S Ciccotto; Robert F Ozols
Phase I trial of multiple cycles of high-dose carboplatin, paclitaxel, and topotecan with peripheral-blood stem-cell support as front-line therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(4):1183-94.
2000: Margaret von Mehren; Philip M Arlen; Kwong-Yok Tsang; André Rogatko; Neal J Meropol; Harry S Cooper; M Davey; Susan McLaughlin; J Schlom; Louis M Weiner
Pilot study of a dual gene recombinant avipox vaccine containing both carcinoembryonic antigen (CEA) and B7.1 transgenes in patients with recurrent CEA-expressing adenocarcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(6):2219-28.
2000: Russell J Schilder; Melvyn Goldberg; Michael Millenson; Benjamin Movsas; André Rogatko; B Rogers; Corey J Langer
Phase II trial of induction high-dose chemotherapy followed by surgical resection and radiation therapy for patients with marginally resectable non-small cell carcinoma of the lung.
Lung cancer (Amsterdam, Netherlands) 2000;27(1):37-45.
1999: André Rogatko; James Babb; H Jordan; S Zacks
Constructing meiotic maps with known error probability.
Genetic epidemiology 1999;16(3):274-89.
1998: James Babb; André Rogatko; S Zacks
Cancer phase I clinical trials: efficient dose escalation with overdose control.
Statistics in medicine 1998;17(10):1103-20.
1997: RC Montgomery; John P Hoffman; LB Riley; André Rogatko; JA Ridge; Burton L Eisenberg
Prediction of recurrence and survival by post-resection CA 19-9 values in patients with adenocarcinoma of the pancreas.
Annals of surgical oncology 1997;4(7):551-6.
1997: Timothy R Rebbeck; H A Jordan; Rhonda E Schnur; André Rogatko
Utility of linked markers in genetic counseling: estimation of carrier risks in X-linked ocular albinism.
American journal of medical genetics 1997;70(1):58-66.
1997: Timothy R Rebbeck; André Rogatko; Marlos Viana
Evaluation of genotype data in clinical risk assessment: methods and application to BRCA1, BRCA2, and N-acetyl transferase-2 genotypes in breast cancer.
Genetic testing 1997;1(3):157-64.
1996: C K Obasaju; S W Johnson; André Rogatko; D Kilpatrick; J M Brennan; Thomas C Hamilton; Robert F Ozols; Peter J O'Dwyer; James M Gallo
Evaluation of carboplatin pharmacokinetics in the absence and presence of paclitaxel.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(3):549-52.
1995: André Rogatko; Timothy R Rebbeck; S Zacks
Risk prediction with linked markers: pedigree analysis.
American journal of medical genetics 1995;59(1):24-32.
1995: André Rogatko
Risk prediction with linked markers: theory.
American journal of medical genetics 1995;59(1):14-23.
1995: A Hageboutros; André Rogatko; E M Newman; Cecilia McAleer; J Brennan; F P LaCreta; Gary R Hudes; Robert F Ozols; Peter J O'Dwyer
Phase I study of phosphonacetyl-L-aspartate, 5-fluorouracil, and leucovorin in patients with advanced cancer.
Cancer chemotherapy and pharmacology 1995;35(3):205-12.
1994: J L Gwin; Andres Klein-Szanto; S Y Zhang; P Agarwal; André Rogatko; Steven M Keller
Loss of blood group antigen A in non-small cell lung cancer.
Annals of surgical oncology 1994;1(5):423-7.
1994: Russell J Schilder; F P LaCreta; R P Perez; S W Johnson; J M Brennan; André Rogatko; S Nash; Cecilia McAleer; Thomas C Hamilton; D Roby
Phase I and pharmacokinetic study of ormaplatin (tetraplatin, NSC 363812) administered on a day 1 and day 8 schedule.
Cancer research 1994;54(3):709-17.
1993: André Rogatko; S Zacks
Ordering genes: controlling the decision-error probabilities.
American journal of human genetics 1993;52(5):947-57.
1992: N Shah; O Del Valle; R Edmondson; G Acampora; D Dwyer; D Matarazzo; André Rogatko; A Thorne; R F Bedford
Esmolol infusion during nitroprusside-induced hypotension: impact on hemodynamics, ventricular performance, and venous admixture.
Journal of cardiothoracic and vascular anesthesia 1992;6(2):196-200.
1992: Peter W T Pisters; Eugenio Cersosimo; André Rogatko; Murray F Brennan
Insulin action on glucose and branched-chain amino acid metabolism in cancer cachexia: differential effects of insulin.
Surgery 1992;111(3):301-10.
1992: E A Klein; André Rogatko; Harry W Herr
Management of local bacillus Calmette-Guerin failures in superficial bladder cancer.
The Journal of urology 1992;147(3):601-5.
1991: Daniel G Coit; André Rogatko; Murray F Brennan
Prognostic factors in patients with melanoma metastatic to axillary or inguinal lymph nodes. A multivariate analysis.
Annals of surgery 1991;214(5):627-36.
1991: Ronald Joseph Younes; André Rogatko; Murray F Brennan
The hemodynamic response to hemorrhage in tumor-bearing animals.
Surgery 1991;110(3):508-13.
1991: P D de Rooij; André Rogatko; Murray F Brennan
Evaluation of palliative surgical procedures in unresectable pancreatic cancer.
The British journal of surgery 1991;78(9):1053-8.
1991: Ronald Joseph Younes; André Rogatko; Murray F Brennan
The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases.
Annals of surgery 1991;214(2):107-13.
1991: Eugenio Cersosimo; Peter W T Pisters; G Pesola; André Rogatko; N A Vydelingum; Daiva Regina Bajorunas; Murray F Brennan
The effect of graded doses of insulin on peripheral glucose uptake and lactate release in cancer cachexia.
Surgery 1991;109(4):459-67.
1991: Ronald Joseph Younes; André Rogatko; N A Vydelingum; Murray F Brennan
Effects of hypovolemia and transfusion on tumor growth in MCA-tumor-bearing rats.
Surgery 1991;109(3 Pt 1):307-12.
1991: Mary S Brady; André Rogatko; Lemuel Leon Dent; M H Shiu
Effect of splenectomy on morbidity and survival following curative gastrectomy for carcinoma.
Archives of surgery (Chicago, Ill. : 1960) 1991;126(3):359-64.
1991: R G Bevilacqua; André Rogatko; S I Hajdu; Murray F Brennan
Prognostic factors in primary retroperitoneal soft-tissue sarcomas.
Archives of surgery (Chicago, Ill. : 1960) 1991;126(3):328-34.
1991: Jeanne A Petrek; R Dukoff; André Rogatko
Prognosis of pregnancy-associated breast cancer.
Cancer 1991;67(4):869-72.
1991: Harry W Herr; E A Klein; André Rogatko
Local BCG failures in superficial bladder cancer. A multivariate analysis of risk factors influencing survival.
European urology 1991;19(2):97-100.
1991: carlo vitelli; K Cooper; André Rogatko; Murray F Brennan
Cardiopulmonary resuscitation and the patient with cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(1):111-5.
1990: R G Bevilacqua; Daniel G Coit; André Rogatko; Ronald Joseph Younes; Murray F Brennan
Axillary dissection in melanoma. Prognostic variables in node-positive patients.
Annals of surgery 1990;212(2):125-31.
1990: Jeanne A Petrek; M M Peters; Subhadra Nori; C Knauer; D W Kinne; André Rogatko
Axillary lymphadenectomy. A prospective, randomized trial of 13 factors influencing drainage, including early or delayed arm mobilization.
Archives of surgery (Chicago, Ill. : 1960) 1990;125(3):378-82.
1989: Joel Sheinfeld; A J Schaeffer; Carlos Cordon-Cardo; André Rogatko; W R Fair
Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women.
The New England journal of medicine 1989;320(12):773-7.
1989: Arleen D Auerbach; André Rogatko; T M Schroeder-Kurth
International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity.
Blood 1989;73(2):391-6.
1989: André Rogatko; S Zacks
Statistical inference in the gene order problem: theoretical aspects.
Progress in clinical and biological research 1989;329():63-8.
1988: Stephanie L Sherman; André Rogatko; G Turner
Recurrence risks for relatives in families with an isolated case of the fragile X syndrome.
American journal of medical genetics 1988;31(4):753-65.
1988: André Rogatko
Evaluating the uncertainty of risk prediction in genetic counseling: a Bayesian approach.
American journal of medical genetics 1988;31(3):513-9.
1988: André Rogatko; Arleen D Auerbach
Segregation analysis with uncertain ascertainment: application to Fanconi anemia.
American journal of human genetics 1988;42(6):889-97.